Literature DB >> 17341664

Malarial anemia: of mice and men.

Abigail A Lamikanra1, Douglas Brown, Alexandre Potocnik, Climent Casals-Pascual, Jean Langhorne, David J Roberts.   

Abstract

Severe malaria is manifest by a variety of clinical syndromes dependent on properties of both the host and the parasite. In young infants, severe malarial anemia (SMA) is the most common syndrome of severe disease and contributes substantially to the considerable mortality and morbidity from malaria. There is now growing evidence, from both human and mouse studies of malaria, to show that anemia is due not only to increased hemolysis of infected and clearance of uninfected red blood cells (RBCs) but also to an inability of the infected host to produce an adequate erythroid response. In this review, we will summarize the recent clinical and experimental studies of malaria to highlight similarities and differences in human and mouse pathology that result in anemia and so inform the use of mouse models in the study of severe malarial anemia in humans.

Entities:  

Mesh:

Year:  2007        PMID: 17341664     DOI: 10.1182/blood-2006-09-018069

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  113 in total

1.  Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: a double stable-isotope study in young Beninese women.

Authors:  Colin I Cercamondi; Ines M Egli; Ella Ahouandjinou; Romain Dossa; Christophe Zeder; Lamidhi Salami; Harold Tjalsma; Erwin Wiegerinck; Toshihiko Tanno; Richard F Hurrell; Joseph Hounhouigan; Michael B Zimmermann
Journal:  Am J Clin Nutr       Date:  2010-10-06       Impact factor: 7.045

2.  In vivo splenic clearance correlates with in vitro deformability of red blood cells from Plasmodium yoelii-infected mice.

Authors:  Sha Huang; Anburaj Amaladoss; Min Liu; Huichao Chen; Rou Zhang; Peter R Preiser; Ming Dao; Jongyoon Han
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  Eryptosis of non-parasitized erythrocytes is related to anemia in Plasmodium berghei low parasitema malaria of Wistar rats.

Authors:  Paulo Renato Rivas Totino; Hugo Amorim Dos Santos de Souza; Edmar Henrique Costa Correa; Cláudio Tadeu Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Parasitol Res       Date:  2018-12-01       Impact factor: 2.289

4.  Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia.

Authors:  Philip E Thuma; Janneke van Dijk; Rick Bucala; Zufan Debebe; Sergei Nekhai; Thea Kuddo; Mehdi Nouraie; Günter Weiss; Victor R Gordeuk
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

5.  Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria.

Authors:  Robin Kobbe; Nadine Schreiber; Jürgen May; Thomas Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2008-02-11       Impact factor: 5.191

6.  In-vivo antimalarial activity of aqueous leaf and bark extracts of Trema orientalis against Plasmodium berghei in mice.

Authors:  Oluwatoyosi Eniola Oyebola; Olajumoke Abimbola Morenikeji; Isaiah Oluwafemi Ademola
Journal:  J Parasit Dis       Date:  2016-07-07

Review 7.  Malaria, erythrocytic infection, and anemia.

Authors:  Kasturi Haldar; Narla Mohandas
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

8.  Dynamic deformability of Plasmodium falciparum-infected erythrocytes exposed to artesunate in vitro.

Authors:  Sha Huang; Andreas Undisz; Monica Diez-Silva; Hansen Bow; Ming Dao; Jongyoon Han
Journal:  Integr Biol (Camb)       Date:  2013-02       Impact factor: 2.192

Review 9.  Murine infection models for vaccine development: the malaria example.

Authors:  Kai Matuschewski
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

Review 10.  Potential immune mechanisms associated with anemia in Plasmodium vivax malaria: a puzzling question.

Authors:  Thiago Castro-Gomes; Luiza C Mourão; Gisely C Melo; Wuelton M Monteiro; Marcus V G Lacerda; Érika M Braga
Journal:  Infect Immun       Date:  2014-08-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.